{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:38:52Z","timestamp":1792805932113,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,14]],"date-time":"2020-11-14T00:00:00Z","timestamp":1605312000000},"content-version":"am","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Joint Bone Spine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jbspin.2019.01.012","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:19:00Z","timestamp":1548973140000},"page":"731-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["X-linked hypophosphatemia: Management and treatment prospects"],"prefix":"10.1016","volume":"86","author":[{"given":"Anne-Sophie","family":"Lambert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volha","family":"Zhukouskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anya","family":"Rothenbuhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agn\u00e8s","family":"Linglart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbspin.2019.01.012_bib0005","doi-asserted-by":"crossref","unstructured":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium. Nat Genet. 1995;11:130-136.","DOI":"10.1038\/ng1095-130"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0010","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0015","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EC-13-0103","article-title":"Therapeutic management of hypophosphatemic rickets from infancy to adulthood","volume":"3","author":"Linglart","year":"2014","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1530\/EJE-15-0661","article-title":"Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms","volume":"174","author":"Che","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0025","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1210\/jc.2003-030036","article-title":"Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets","volume":"88","author":"M\u00e4kitie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0030","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1067\/mpd.2003.119","article-title":"Dental abnormalities in patients with familial hypophosphatemic vitamin D-resistant rickets: prevention by early treatment with 1-hydroxyvitamin D","volume":"142","author":"Chaussain-Miller","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0035","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1177\/0022034516677528","article-title":"Phosphate and vitamin d prevent periodontitis in X-linked hypophosphatemia","volume":"96","author":"Biosse Duplan","year":"2017","journal-title":"J Dent Res"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0040","doi-asserted-by":"crossref","first-page":"E954","DOI":"10.1210\/jc.2012-4133","article-title":"Cortical and trabecular bone density in X-linked hypophosphatemic rickets","volume":"98","author":"Cheung","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0045","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00439-009-0631-z","article-title":"PHEX analysis in 118 pedigrees reveals new genetic clues in hypophosphatemic rickets","volume":"125","author":"Gaucher","year":"2009","journal-title":"Hum Genet"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00862587","article-title":"Assessment of maximal tubular phosphate reabsorption: comparison of direct measurement with the nomogram of Bijvoet","volume":"2","author":"Brodehl","year":"1988","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0055","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00467-012-2364-9","article-title":"Hypophosphatemia and growth","volume":"28","author":"Santos","year":"2013","journal-title":"Pediatr Nephrol Berl Ger"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0060","first-page":"22","article-title":"Genu varum and genu valgum in children: differential diagnosis and guidelines for evaluation","volume":"22","author":"Greene","year":"1996","journal-title":"Compr Ther"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0065","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00223-010-9373-0","article-title":"Phenotype presentation of hypophosphatemic rickets in adults","volume":"87","author":"Beck-Nielsen","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0070","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s10545-018-0147-6","article-title":"Outcome of adult patients with X-linked hypophosphatemia caused by PHEX gene mutations","volume":"41","author":"Chesher","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0075","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20180022","article-title":"Radiation dose optimisation for conventional imaging in infants and newborns using automatic dose management software: an application of the new 2013\/59 EURATOM directive","volume":"91","author":"Alejo","year":"2018","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0080","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1148\/radiology.171.2.2539609","article-title":"X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features","volume":"171","author":"Hardy","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11832-016-0713-0","article-title":"EOS\u00ae biplanar X-ray imaging: concept, developments, benefits, and limitations","volume":"10","author":"Melhem","year":"2016","journal-title":"J Child Orthop"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0090","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/ocr.12120","article-title":"A radiological study on intra- and extra-cranial calcifications in adults with X-linked hypophosphatemia and associations with other mineralizing enthesopathies and childhood medical treatment","volume":"19","author":"Gj\u00f8rup","year":"2016","journal-title":"Orthod Craniofac Res"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0095","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1210\/JC.2015-2199","article-title":"Conventional therapy in adults with X-linked hypophosphatemia: Effects on enthesopathy and dental disease","volume":"100","author":"Connor","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0100","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00467-004-1443-y","article-title":"The enigma of hyperparathyroidism in hypophosphatemic rickets","volume":"19","author":"Schmitt","year":"2004","journal-title":"Pediatr Nephrol Berl Ger."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2265.2003.01685.x","article-title":"Prolonged high-dose phosphate treatment: a risk factor for tertiary hyperparathyroidism in X-linked hypophosphatemic rickets","volume":"58","author":"Makitie","year":"2003","journal-title":"Clin Endocrinol Oxf"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0110","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0115","doi-asserted-by":"crossref","first-page":"E352","DOI":"10.1210\/jc.2010-0589","article-title":"Circulating levels of soluble klotho and FGF23 in X-linked hypophosphatemia: circadian variance, effects of treatment, and relationship to parathyroid status","volume":"95","author":"Carpenter","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0120","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3171\/2015.10.PEDS15273","article-title":"Hypophosphatemic rickets and craniosynostosis: a multicenter case series","volume":"17","author":"Vega","year":"2016","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1017\/S0022215107001636","article-title":"Hearing loss and fluctuating hearing levels in X-linked hypophosphataemic osteomalacia","volume":"123","author":"Pantel","year":"2009","journal-title":"J Laryngol Otol"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0130","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1056\/NEJM199112263252604","article-title":"Effects of therapy in X-linked hypophosphatemic rickets","volume":"325","author":"Verge","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0135","doi-asserted-by":"crossref","first-page":"E990","DOI":"10.1210\/jc.2012-4146","article-title":"The muscle-bone relationship in X-linked hypophosphatemic rickets","volume":"98","author":"Veilleux","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0140","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00431-014-2454-8","article-title":"Sex-, age-, and height-specific reference curves for the 6-min walk test in healthy children and adolescents","volume":"174","author":"Saraff","year":"2015","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0145","unstructured":"hypophosphatemies_hereditaires_a_fgf23_eleve_dont_hypophosphatemies_liees_a_lx_-_pnds.pdf [Internet]. [cit\u00e9 19 ao\u00fbt 2018]. Disponible sur: https:\/\/www.has-sante.fr\/portail\/upload\/docs\/application\/pdf\/2018-05\/hypophosphatemies_hereditaires_a_fgf23_eleve_dont_hypophosphatemies_liees_a_lx_-_pnds.pdf."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0150","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1530\/EC-17-0154","article-title":"Outcomes of orthopedic surgery in a cohort of 49 patients with X-linked hypophosphatemic rickets (XLHR)","volume":"6","author":"Gizard","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0155","unstructured":"761068s000lbl.pdf [Internet]. [accessed on June 27, 2018]. Available at https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/761068s000lbl.pdf."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0160","unstructured":"WC500245537.pdf [Internet]. [accessed on June 27, 2018]. Available at http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/004275\/WC500245537.pdf."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0165","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0170","unstructured":"Presentations & Publications | Rare Disease Drug Development | Ultragenyx [Internet]. [accessed on February cit\u00e9 10, 2018]. Available at http:\/\/www.ultragenyx.com\/pipeline\/publications\/."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0175","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1210\/jc.2011-0399","article-title":"Three-year growth hormone treatment in short children with X-linked hypophosphatemic rickets: effects on linear growth and body disproportion","volume":"96","author":"\u017divi\u010dnjak","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ghir.2017.08.001","article-title":"Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)","volume":"36","author":"Rothenbuhler","year":"2017","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0185","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1302\/1863-2548.12.170050","article-title":"Guided growth: preliminary results of a multinational study of 967 physes in 537 patients","volume":"12","author":"Danino","year":"2018","journal-title":"J Child Orthop"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0190","first-page":"879","article-title":"A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets","volume":"75","author":"Sullivan","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0195","first-page":"A4874","article-title":"Treatment of hypophosphataemic rickets in children remains a challenge","volume":"61","author":"Nielsen","year":"2014","journal-title":"Dan Med J"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.joca.2014.01.003","article-title":"OARSI guidelines for the non-surgical management of knee osteoarthritis","volume":"22","author":"McAlindon","year":"2014","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0205","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/jbmr.3475","article-title":"A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with X-linked hypophosphatemia: Week 24 primary analysis","volume":"33","author":"Insogna","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jbspin.2019.01.012_bib0210","unstructured":"Presentations & Publications | Rare Disease Drug Development | Ultragenyx [Internet]. [accessed on February 10, 2018]. Available at http:\/\/www.ultragenyx.com\/pipeline\/publications\/."},{"key":"10.1016\/j.jbspin.2019.01.012_bib0215","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4274\/jcrpe.v3i1.02","article-title":"Serum alkaline phosphatase levels in healthy children and evaluation of alkaline phosphatase z-scores in different types of rickets","volume":"3","author":"Turan","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol"}],"container-title":["Joint Bone Spine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1297319X19300107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T16:26:53Z","timestamp":1761150413000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1297319X19300107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1297319X19300107"],"URL":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.012","relation":{},"ISSN":["1297-319X"],"issn-type":[{"value":"1297-319X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"X-linked hypophosphatemia: Management and treatment prospects","name":"articletitle","label":"Article Title"},{"value":"Joint Bone Spine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbspin.2019.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie. Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}